ENTITY

Insulet Corp (PODD US)

87
Analysis
Health CareUnited States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
bearishEoflow
08 Oct 2023 19:33

EOFLOW/Medtronic Tender: Proposed Preliminary Injunction Is a Problem

On 6 October, the US judge "after a hearing, and after careful consideration of the pleadings and record evidence" handed down a preliminary...

Logo
2.5k Views
Share
08 Oct 2023 07:05

Last Week in Event SPACE: Monex/NTT, PICC/PICC P&C, Vertex

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
602 Views
Share
bullishEoflow
08 Oct 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: EOFlow, Newcrest, JMDC, Boustead Plantation, Symbio, Aeon

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
607 Views
Share
bullishEoflow
06 Oct 2023 12:39

EOFlow: Insulet's Injunction Doesn't Thwart Medtronic's Acquisition

t makes commercial sense for MDT to complete the EOFlow transaction on schedule, enabling the more financially and legally resource-rich MDT to...

Logo
1.3k Views
Share
bullishEoflow
05 Oct 2023 20:25

Eoflow: Ozempic and Wegovy Reducing Need for Disposable Insulin Injection Devices + Ongoing Lawsuit?

Eoflow's share price has dropped 27% lower than the proposed tender offer price of 30,000 won. In this insight, we discuss two major factors have...

Logo
1.2k Views
Share
x